Zevaquenabant

DESCRIPTION

Zevaquenabant ((S)-MRI-1867), a dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist, is orally bioavailable and peripherally restricted. It effectively mitigates obesity-induced chronic kidney disease (CKD).

DETAILS

Cas: 1998760-00-1
Purity: 98%
Smiles: CC(=N)N=C(NS(=O)(=O)c1ccc(cc1)C(F)(F)F)N1C[C@@H](C(=N1)c1ccc(Cl)cc1)c1ccccc1 |w:3.2,c:23|
Category: Compound
Molecular Weight: 547.98
Molecular Formula: C25H21ClF3N5O2S

Lead Time: Please Inquire